VENTURELLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 10.982
EU - Europa 6.160
AS - Asia 5.814
SA - Sud America 751
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 120
OC - Oceania 15
Totale 24.044
Nazione #
US - Stati Uniti d'America 10.745
IT - Italia 1.908
CN - Cina 1.710
SG - Singapore 1.672
GB - Regno Unito 1.445
DE - Germania 719
VN - Vietnam 686
BR - Brasile 577
SE - Svezia 573
HK - Hong Kong 507
FR - Francia 336
KR - Corea 266
BD - Bangladesh 243
RU - Federazione Russa 239
FI - Finlandia 210
UA - Ucraina 185
IN - India 145
CA - Canada 129
PL - Polonia 109
TR - Turchia 109
ID - Indonesia 87
JP - Giappone 84
BG - Bulgaria 73
NL - Olanda 64
AR - Argentina 57
BE - Belgio 57
IQ - Iraq 56
MX - Messico 49
ES - Italia 42
ZA - Sudafrica 36
IE - Irlanda 33
LT - Lituania 32
AE - Emirati Arabi Uniti 27
EC - Ecuador 27
CL - Cile 26
PK - Pakistan 26
UZ - Uzbekistan 26
AT - Austria 23
CH - Svizzera 22
MY - Malesia 21
SA - Arabia Saudita 20
IR - Iran 19
PH - Filippine 17
TW - Taiwan 15
MA - Marocco 14
VE - Venezuela 14
JO - Giordania 13
CO - Colombia 12
CZ - Repubblica Ceca 12
AU - Australia 11
AZ - Azerbaigian 11
CR - Costa Rica 11
DZ - Algeria 11
PE - Perù 11
PT - Portogallo 11
EG - Egitto 10
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
ET - Etiopia 9
HN - Honduras 9
RO - Romania 9
UY - Uruguay 9
BO - Bolivia 8
IL - Israele 8
JM - Giamaica 8
KZ - Kazakistan 7
NO - Norvegia 7
NP - Nepal 7
RS - Serbia 7
TH - Thailandia 7
AL - Albania 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
SN - Senegal 5
GT - Guatemala 4
NZ - Nuova Zelanda 4
OM - Oman 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
GA - Gabon 3
HR - Croazia 3
HU - Ungheria 3
LV - Lettonia 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
SI - Slovenia 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 23.822
Città #
Ashburn 1.088
Santa Clara 1.029
Singapore 1.019
Southend 926
Fairfield 727
Hefei 605
Chandler 565
San Jose 565
Woodbridge 501
Hong Kong 482
Houston 417
Frankfurt am Main 331
Council Bluffs 328
Seattle 328
Modena 321
Ann Arbor 316
Jacksonville 316
Nyköping 307
Wilmington 282
Cambridge 266
Dearborn 264
Beijing 254
Seoul 254
Ho Chi Minh City 229
London 219
Los Angeles 214
New York 196
Hanoi 157
Chicago 154
Helsinki 131
Milan 109
The Dalles 109
Munich 85
San Diego 84
Shanghai 82
Lauterbourg 80
Moscow 79
Princeton 74
Sofia 70
São Paulo 70
Bologna 67
Buffalo 62
Jakarta 62
Kraków 62
Fremont 61
Orem 58
Dallas 55
Eugene 54
Salt Lake City 53
Boardman 52
Izmir 50
Brussels 46
Tokyo 46
Warsaw 43
Redwood City 42
Bremen 36
Guangzhou 36
Columbus 35
Rome 35
Parma 34
Toronto 31
Dublin 29
Grafing 29
Chennai 28
Denver 28
Phoenix 28
Da Nang 27
Manchester 27
Reggio Emilia 27
Des Moines 26
Haiphong 26
Turku 26
Atlanta 25
Milwaukee 25
Brooklyn 24
Tampa 24
Elk Grove Village 23
Tashkent 23
Montreal 22
Ottawa 22
Turin 22
Baghdad 20
Brescia 20
Stockholm 20
Washington 19
Amsterdam 18
Kent 18
Nanjing 18
Belo Horizonte 17
Boston 17
Johannesburg 17
Sterling 17
Dhaka 16
Rio de Janeiro 16
Padova 15
Dong Ket 14
Ferrara 14
Formigine 14
Paris 14
San Francisco 14
Totale 15.482
Nome #
TYDOCK PHARMA s.r.l. Spin Off dell'Università di Modena e Reggio Emilia che ha come fine l'attività di ricerca e sviluppo nel settore delle biotech farmaceutiche. 688
An Improved Synthesis of CENTA, a Chromogenic Substrate for β-Lactamases 459
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 447
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 445
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 435
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 435
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 432
New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines 430
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 416
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines 407
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-beta-lactamases 394
Structure-based studies on species-specific inhibition of thymidylate synthase 385
Decoding the structural basis for carbapenem hydrolysis by class A β- lactamases: fishing for a pharmacophore 369
Allosteric Inhibition of human Thymidylate Synthase. 367
Multiligand approach to the identification of resistant strains overexpressing beta-lactamase 366
Thymidylate synthase structure, function and implication in drug discovery 362
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 357
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 349
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 343
IN SILICO/IN VITRO APPROACHES FOR THE IDENTIFICATION OF NEW CARBAPENEMASE INHIBITORS 342
X-ray-crystallography deciphers the activity of broad spectrum boronic acid β-Lactamases inhibitors 337
ANTICANCER DRUGS 336
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors 334
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 328
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 324
Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents 323
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 318
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 318
The Inhibition of Extended Spectrum beta-Lactamases: Hits and Leads 315
Permeation through the cell membrane of a boron-based β-lactamase inhibitor. 313
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 307
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 302
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 297
Crystallographic studies of novel inhibitors of [beta]-lactamases 297
Optimization of N-alkylation in the Synthesis of Methotrexate and Pteridine-based Derivatives Under Microwave-Irradiation 293
Pirrole-amidine oligopeptide–DNA interaction studies through Isothermal Titration Calorimetry 290
Target-based approaches for the discovery of new antimycobacterial drugs 282
Long period fiber grating biosensor for the detection of drug resistant bacteria: The 'OPTObacteria' project 281
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 280
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 279
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 277
A new strategy based on microwave-assisted technology for the extraction and purification of beeswax policosanols for pharmaceutical purposes and beyond 277
Feasibility Study on a Measurement Method and a Portable Measuring System to Estimate the Concentration of Cloxacillin and β -Lactamase in Milk 272
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 272
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 264
Naphthofuranone derivatives as specific inhibitors of thymidylate synthases 258
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 256
Label-free fiber optic optrode for the detection of class C beta-lactamases expressed by drug resistant bacteria 253
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 247
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 247
Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative 247
NAPHTHOFURANONE DERIVATIVES AS SPECIFIC INHIBITORS OF THYMIDYLATE SYNTHASES 246
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 244
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 237
Long period fiber grating working in reflection mode as valuable biosensing platform for the detection of drug resistant bacteria 234
Developing New beta-Lactamase Inhibitors Through Structure-Based Design and Pharmacokinetic Improvement 232
Merging disulphide bonds for drug design Interfering with a cancer key protein 232
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 225
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 215
Current Treatments to Control African Trypanosomiasis and One Health Perspective 214
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 212
Coupling a microwave-assisted process with HPLC-ELSD for the extraction, purification and analysis of bioactive policosanols from beeswax 210
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases 204
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 201
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 201
An innovative method for the extraction and HPLC analysis of bioactive policosanols from non-psychoactive Cannabis sativa L. 200
Nuovo trattamento assistito da microonde per la produzione di miscele arricchite in policosanoli da matrici cerose 199
Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]- benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]- benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities 195
Structural and thermodynamic combined studies for inhibitors binding to Thymidylate Synthase 194
Structural and Thermodynamic analysis of novel inhibitors of beta-lactmases. 193
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 192
Expression, purification, and characterization of Transcriptional Enhancer Associated Domain (hTEAD4), a promising target for anticancer agents 189
On the feasibility of a CENTA-based biosensor to measure antibiotics concentration in milk 183
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 182
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 179
Studi termodinamici e strutturali dell’interazione tra derivati densilici e Timidilato Sintasi Batteriche 174
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 173
VIrtual screening identifies cross-class inhibitors of clinically relevant serine- and metallo-beta lactamases 171
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 165
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents 162
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 155
Reflection-type long period grating biosensor for detection of drug resistant bacteria: The OptoBacteria project 147
Reflection-type long period grating biosensor for the detection of drug resistant bacteria: The Opto-bacteria Project 141
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1 140
First total synthesis of the irciniasulfonic acids 136
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 132
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 83
Totale 24.044
Categoria #
all - tutte 89.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.292 0 0 83 63 82 151 70 89 180 110 297 167
2022/20231.830 237 223 136 174 176 243 72 151 240 25 79 74
2023/20241.631 71 89 114 111 537 145 55 142 36 32 141 158
2024/20254.205 152 45 137 248 758 548 308 253 429 178 544 605
2025/20267.647 530 407 590 943 1.186 496 944 332 645 693 534 347
2026/2027829 199 440 190 0 0 0 0 0 0 0 0 0
Totale 24.044